Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kuhnke

Showing results (141-150 of 160) with videos related to

Pageof 16
Sort By:
Journal of Neurology, Neurosurgery, and Psychiatry|May 6, 2026
Autologous haematopoietic stem cell transplantation in multiple sclerosis: outcomes and predictors from German real-world dataFelix Fischbach, Johanna Richter, Miriam Korporal-Kuhnke, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 7, 2023
Humoral COVID-19 vaccine response in patients with NMOSD/MOGAD during anti-IL-6 receptor therapy compared to other immunotherapiesCarolin Schwake, Thivya Pakeerathan, Ingo Kleiter, et al.
Brain, Behavior, and Immunity|August 13, 2025
Specific viral antibodies associate with anti-NMDAR encephalitis after herpes simplex encephalitisJakob Kreye, William R Morgenlander, Manjusha Thakar, et al.
Journal of Neuroinflammation|September 5, 2020
Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 1: Results from 163 lumbar punctures in 100 adult patientsSven Jarius, Hannah Pellkofer, Nadja Siebert, et al.
Journal of Neuroinflammation|November 3, 2016
MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 3: Brainstem involvement - frequency, presentation and outcomeSven Jarius, Ingo Kleiter, Klemens Ruprecht, et al.
Journal of Neuroinflammation|October 30, 2016
MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and originSven Jarius, Klemens Ruprecht, Ingo Kleiter, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|July 7, 2025
Comorbidities and Their Influence on Outcomes and Infectious Complications in Autoimmune Encephalitis: A Multicenter Cohort StudyAmelie Bohn, Klemens Angstwurm, Christian G Bien, et al.
Journal of Neuroinflammation|October 30, 2016
MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcomeSven Jarius, Klemens Ruprecht, Ingo Kleiter, et al.
Therapeutic Advances in Neurological Disorders|October 2, 2023
Autologous haematopoietic stem cell transplantation for multiple sclerosis: a position paper and registry outlineAntonios Bayas, Achim Berthele, Norbert Blank, et al.
Regulatory Toxicology and Pharmacology : RTP|February 17, 2016
Extending (Q)SARs to incorporate proprietary knowledge for regulatory purposes: A case study using aromatic amine mutagenicityErnst Ahlberg, Alexander Amberg, Lisa D Beilke, et al.
Pageof 16

Showing results (141-150 of 160) with videos related to

Sort By:
Pageof 16
Journal of Neurology, Neurosurgery, and Psychiatry|May 6, 2026
Autologous haematopoietic stem cell transplantation in multiple sclerosis: outcomes and predictors from German real-world dataFelix Fischbach, Johanna Richter, Miriam Korporal-Kuhnke, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 7, 2023
Humoral COVID-19 vaccine response in patients with NMOSD/MOGAD during anti-IL-6 receptor therapy compared to other immunotherapiesCarolin Schwake, Thivya Pakeerathan, Ingo Kleiter, et al.
Brain, Behavior, and Immunity|August 13, 2025
Specific viral antibodies associate with anti-NMDAR encephalitis after herpes simplex encephalitisJakob Kreye, William R Morgenlander, Manjusha Thakar, et al.
Journal of Neuroinflammation|September 5, 2020
Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 1: Results from 163 lumbar punctures in 100 adult patientsSven Jarius, Hannah Pellkofer, Nadja Siebert, et al.
Journal of Neuroinflammation|November 3, 2016
MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 3: Brainstem involvement - frequency, presentation and outcomeSven Jarius, Ingo Kleiter, Klemens Ruprecht, et al.
Journal of Neuroinflammation|October 30, 2016
MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and originSven Jarius, Klemens Ruprecht, Ingo Kleiter, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|July 7, 2025
Comorbidities and Their Influence on Outcomes and Infectious Complications in Autoimmune Encephalitis: A Multicenter Cohort StudyAmelie Bohn, Klemens Angstwurm, Christian G Bien, et al.
Journal of Neuroinflammation|October 30, 2016
MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcomeSven Jarius, Klemens Ruprecht, Ingo Kleiter, et al.
Therapeutic Advances in Neurological Disorders|October 2, 2023
Autologous haematopoietic stem cell transplantation for multiple sclerosis: a position paper and registry outlineAntonios Bayas, Achim Berthele, Norbert Blank, et al.
Regulatory Toxicology and Pharmacology : RTP|February 17, 2016
Extending (Q)SARs to incorporate proprietary knowledge for regulatory purposes: A case study using aromatic amine mutagenicityErnst Ahlberg, Alexander Amberg, Lisa D Beilke, et al.
Pageof 16